ENDURANCE-2: Safety and Efficacy of Abt-493/Abt-530 in Hepatitis C Virus Genotype 2-Infected Patients Without Cirrhosis, a Randomized, Double-Blind, Placebo-Controlled Study
67Th Annual Meeting of the American-Association-For-The-Study-Of-Liver-Diseases (Aasld), Date: NOV 11-15, 2016, Location: Boston, MA, Patrocinadores: Amer Assoc Study Liver Dis
